ArticleAmerican journal of respiratory and critical care medicine2024
Inhibiting Invariant Natural Killer T-Cell Activation: A Promising Strategy against Pulmonary Fibrosis.
Taro Yasuma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.